Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_session5i1tb4aa2n9m9jkns5htdt0531bj6bml): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Rinsho Ketsueki
Laboratory of DNA Damage Signaling, Department of Late Effects Studies, Radiation Biology Center, Kyoto.
Published: February 2025
Fanconi anemia (FA) is a rare hereditary disorder characterized by hypersensitivity to the interstrand crosslinks (ICLs) induced by cisplatin, mitomycin C, or formaldehyde. We found that inhibition of SLFN11, which has been identified as a dominant determinant of responses to various antitumor drugs such as cisplatin, camptothecin, and PARP inhibitors, rescued ICL sensitivity and partially alleviated FA phenotype by stabilizing replication forks. This suggests that SLFN11 intensifies DNA damage sensitivity in FA cells, and could be a novel therapeutic target for the FA phenotype. We also found that human SLFN11 and mouse Slfn8/9 share a functional similarity. In this review, we summarize the interplay between SLFN11 and DNA damage, including functional analysis of SLFN11 and its mouse ortholog.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.11406/rinketsu.65.1353 | DOI Listing |
Am J Med Genet A
March 2025
Institute of Biomedical and Clinical Science, RILD Wellcome Wolfson Centre, University of Exeter Medical School, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK.
Prenatal and neonatal presentations of multiple congenital anomalies are difficult to diagnose and are associated with an increased risk of lethality. The differential diagnosis of antenatal presentations of radial ray malformations includes Fanconi anemia (FA), an inherited bone marrow failure disorder associated with congenital anomalies in around 75% of affected individuals. Although no definitive genotype-phenotype correlations have been demonstrated, a more severe presentation has been proposed in association with biallelic loss of function variants as opposed to hypomorphic missense variants.
View Article and Find Full Text PDFNat Commun
March 2025
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
To counteract the damaging effects of DNA interstrand crosslinks (ICLs), cells have evolved various specialized ICL repair pathways. However, how ICL repair impacts genetic integrity remains incompletely understood. Here, we determined the mutagenic consequences of psoralen ICL repair in the animal model C.
View Article and Find Full Text PDFNeuro Oncol
March 2025
Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
Background: Factors that drive the development of diffuse midline gliomas (DMG) are unknown. Our study aimed to determine the prevalence of pathogenic/likely pathogenic (P/LP) germline variants in pediatric patients with DMG.
Methods: We assembled an international cohort of 252 pediatric patients with DMG, including diffuse intrinsic pontine glioma (n=153), with germline whole genome or whole exome sequencing.
Hum Reprod Open
February 2025
Chair of Human Genetics, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Study Question: What is the load and profile of hereditary cancer-linked germline variants in infertile compared to fertile men?
Summary Answer: This study showed almost 5-fold enrichment of disease-causing findings in hereditary cancer genes in infertile compared to fertile men (6.9% vs 1.5%, =2.
bioRxiv
February 2025
Department of Genome Sciences, University of Washington, Seattle, WA.
Fanconi Anemia (FA) is a heritable syndrome characterized by DNA damage repair deficits, frequent malformations and a significantly elevated risk of bone marrow failure, leukemia, and mucosal head and neck squamous cell carcinomas (HNSCC). Hematopoietic stem cell gene therapy can prevent marrow failure and lower leukemia risk, but mucosal gene therapy to lower HNSCC risk remains untested. Major knowledge gaps include an incomplete understanding of how rapidly gene-corrected cellular lineages could spread through the oral epithelium, and which delivery parameters are critical for ensuring efficient gene correction.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.